Tenofovir disoproxil fumarate (300 mg) Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Tenofovir disoproxil fumarate (300 mg) Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: NRTI (TDF)
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Tenofovir disoproxil fumarate (300 mg) Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Tenofovir disoproxil fumarate (300 mg) Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Tenofovir disoproxil fumarate (300 mg) Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Tenofovir disoproxil fumarate (300 mg) formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- HIV-1 infection (ART backbone)
- Chronic hepatitis B
- HIV-HBV co-infection
- Pre-exposure prophylaxis (PrEP)
Mechanism of Action
Tenofovir is a nucleotide reverse transcriptase inhibitor (NRTI) — phosphorylated intracellularly to active form that competitively inhibits HIV/HBV reverse transcriptase and incorporates into viral DNA causing chain termination.
Dosage & Administration
- Adults: 300 mg once daily.
Side Effects
- Renal dysfunction (monitor creatinine, phosphate), bone density loss (long-term), GI upset, headache.
Contraindications
- Severe renal impairment (eGFR <30 — use TAF instead), hypersensitivity.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
PCD Pharma Franchise for Tenofovir disoproxil fumarate (300 mg) Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: Bottle (30 Tab)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Tenofovir disoproxil fumarate (300 mg) Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Tenofovir disoproxil fumarate (300 mg) Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Tenofovir disoproxil fumarate (300 mg) Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Tenofovir disoproxil fumarate (300 mg) Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Tenofovir disoproxil fumarate (300 mg) Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Tenofovir disoproxil fumarate (300 mg) Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Tenofovir disoproxil fumarate (300 mg) Tablet?
Available pack sizes include: Bottle (30 Tab).
What is the MRP / trade price for Tenofovir disoproxil fumarate (300 mg) Tablet?
MRPs range from ₹1350 to ₹1350 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Tenofovir disoproxil fumarate (300 mg) Tablet?